Cargando…

Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review

BACKGROUND: Pneumonia is one of the leading hospital-acquired infections worldwide and has an important impact. Although preventive measures for ventilator-associated pneumonia (VAP) are well known, less is known about appropriate measures for prevention of hospital-acquired pneumonia (HAP). AIM: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pássaro, Leonor, Harbarth, Stephan, Landelle, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109660/ https://www.ncbi.nlm.nih.gov/pubmed/27895901 http://dx.doi.org/10.1186/s13756-016-0150-3

Ejemplares similares

Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?
por: Landelle, Caroline, et al.
Publicado: (2013)

Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
por: Abdalla, Jehad S., et al.
Publicado: (2023)

93. Enhanced Oral Care as Prevention for Non-ventilator Hospital Acquired Pneumonia
por: Giuliano, Karen K, et al.
Publicado: (2020)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
por: Landelle, C., et al.
Publicado: (2018)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Ventilator-associated pneumonia in adults: a narrative review
por: Papazian, Laurent, et al.
Publicado: (2020)

Ventilator-Associated Pneumonia Prevention in Pediatric Patients: Narrative Review
por: Antalová, Natália, et al.
Publicado: (2022)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
por: Rubinstein, Ethan, et al.
Publicado: (2014)

Incidence and outcomes of hospitalization for community-acquired, ventilator-associated and non-ventilator hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain
por: Lopez-de-Andres, Ana, et al.
Publicado: (2020)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Correction: Incidence and outcomes of hospitalization for community-acquired, Ventilator-associated and non-ventilator Hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain
Publicado: (2020)

What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020)

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2018)

Dental and Microbiological Risk Factors for Hospital-Acquired Pneumonia in Non-Ventilated Older Patients
por: Ewan, Victoria C., et al.
Publicado: (2015)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)

Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Marti, Christophe, et al.
Publicado: (2015)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Prevention of ventilator-associated pneumonia in adults
por: Prescott, Hallie C, et al.
Publicado: (2010)

Incidence and Outcomes of Non–Ventilator-Associated Hospital-Acquired Pneumonia in 284 US Hospitals Using Electronic Surveillance Criteria
por: Jones, Barbara E., et al.
Publicado: (2023)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Hospitalizations for Community-Acquired and Non-Ventilator-Associated Hospital-Acquired Pneumonia in Spain: Influence of the Presence of Bronchiectasis. A Retrospective Database Study
por: Sanchez-Muñoz, Gema, et al.
Publicado: (2020)

Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia,
por: Seligman, Renato, et al.
Publicado: (2013)

Pathogenesis-Targeted Preventive Strategies for Multidrug Resistant Ventilator-Associated Pneumonia: A Narrative Review
por: Cotoia, Antonella, et al.
Publicado: (2020)

Non-invasive pressure support ventilation in severe community-acquired pneumonia
por: Jolliet, Philippe, et al.
Publicado: (2001)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

Utilization Trends and Predictors of Non-invasive and Invasive Ventilation During Hospitalization Due to Community-Acquired Pneumonia
por: Shah, Harshil, et al.
Publicado: (2021)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia
por: Garin, Nicolas, et al.
Publicado: (2016)

Development and validation of a semi-automated surveillance system—lowering the fruit for non-ventilator-associated hospital-acquired pneumonia (nvHAP) prevention()
por: Wolfensberger, A., et al.
Publicado: (2019)

Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2021)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Clinical review: Non-antibiotic strategies for preventing ventilator-associated pneumonia
por: Ferrer, Ricard, et al.
Publicado: (2002)

Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review
por: Garin, Nicolas, et al.
Publicado: (2022)

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
por: Piskin, Nihal, et al.
Publicado: (2012)

Cost–effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia
por: Naik, Jaesh, et al.
Publicado: (2023)

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)

Implementation of a ventilator care bundle to reduce the incidence of ventilator acquired pneumonia
por: Mandal, AK, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i23uoi3us0ds155pde4sifsaj2